PT93806A - Processo para a preparacao de composicoes farmaceuticas contendo 7-(amino substituido)-8-(carbonil substituido)-metilamino-11oxa-espiro(4,5) decanos com efeito diuretico anti-inflamatorio, e cerebro-vascular - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo 7-(amino substituido)-8-(carbonil substituido)-metilamino-11oxa-espiro(4,5) decanos com efeito diuretico anti-inflamatorio, e cerebro-vascular

Info

Publication number
PT93806A
PT93806A PT93806A PT9380690A PT93806A PT 93806 A PT93806 A PT 93806A PT 93806 A PT93806 A PT 93806A PT 9380690 A PT9380690 A PT 9380690A PT 93806 A PT93806 A PT 93806A
Authority
PT
Portugal
Prior art keywords
substituted
11oxa
metilamino
espiro
dean
Prior art date
Application number
PT93806A
Other languages
English (en)
Other versions
PT93806B (pt
Inventor
David Christopher Horwell
David Charles Rees
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT93806A publication Critical patent/PT93806A/pt
Publication of PT93806B publication Critical patent/PT93806B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT93806A 1989-04-21 1990-04-19 Processo para a preparacao de composicoes farmaceuticas contendo 7-(amino substituido)-8-(carbonil substituido)-metilamino-11oxa-espiro(4,5) decanos com efeito diuretico anti-inflamatorio, e cerebro-vascular PT93806B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/341,336 US4965278A (en) 1989-04-21 1989-04-21 7-(substituted)amino)-8-((substituted)carbonyl)-methylamino)-1-oxaspiro[4,5]decanes as diuretics antiiflammatory, and cerebrovascular agents

Publications (2)

Publication Number Publication Date
PT93806A true PT93806A (pt) 1990-11-20
PT93806B PT93806B (pt) 1996-09-30

Family

ID=23337122

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93806A PT93806B (pt) 1989-04-21 1990-04-19 Processo para a preparacao de composicoes farmaceuticas contendo 7-(amino substituido)-8-(carbonil substituido)-metilamino-11oxa-espiro(4,5) decanos com efeito diuretico anti-inflamatorio, e cerebro-vascular

Country Status (10)

Country Link
US (1) US4965278A (pt)
EP (1) EP0393696A3 (pt)
JP (1) JP3070930B2 (pt)
KR (1) KR0149491B1 (pt)
AU (1) AU622312B2 (pt)
CA (1) CA2014957A1 (pt)
IE (1) IE64852B1 (pt)
NZ (1) NZ233376A (pt)
PT (1) PT93806B (pt)
ZA (1) ZA903016B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317028A (en) * 1992-09-08 1994-05-31 Warner-Lambert Co. 7-((substituted)amino)-8((substituted)carbonyl)-methylamino-1-oxaspiro(4,5)decanes useful in Parkinson's disease, dystonia, and other movement disorders
US5369120A (en) * 1993-07-28 1994-11-29 Warner-Lambert Company Pharmaceutical composition of 7-((substituted)amino-8-((substituted)carbonyl)-(methylamino)-1-oxasp iro(4,5)decanes and L-dopa
US5489607A (en) * 1995-02-16 1996-02-06 Warner-Lambert Company Use of enadoline in the treatment of benign prostatic enlargement
US6239154B1 (en) 1996-03-08 2001-05-29 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US5763445A (en) 1996-03-08 1998-06-09 Adolor Corporation Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
US20020188268A1 (en) 1999-06-30 2002-12-12 Mark James Kline Elastomeric side panel for use with convertible absorbent articles
US5859043A (en) * 1996-06-11 1999-01-12 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for maintaining kidney function during surgery or severe trauma under general anesthesia
US6468971B1 (en) 1997-03-05 2002-10-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Maintaining kidney function during surgery or trauma
WO1999003459A1 (en) * 1997-07-14 1999-01-28 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
US5760023A (en) * 1997-07-14 1998-06-02 Adolor Corporation Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
GB0123571D0 (en) * 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
US7964800B2 (en) * 2006-05-25 2011-06-21 Fujikura Ltd. Printed wiring board, method for forming the printed wiring board, and board interconnection structure

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT376669B (de) 1982-11-26 1984-12-27 Laevosan Gmbh & Co Kg Verfahren zur herstellung neuer thienylessigsaeureamid-derivate und pharmazeutisch vertraeglicher saeureadditionssalze davon
US4598087A (en) 1983-12-06 1986-07-01 Warner-Lambert Company Substituted trans-1,2-diaminocyclohexyl amide compounds
US4618621A (en) * 1984-09-21 1986-10-21 The Upjohn Company Method for treating medical conditions involving cerebral ischemia
US4737493A (en) * 1985-07-01 1988-04-12 Warner-Lambert Company 7-((substituted)amino)-8-((substituted)carbonyl)-methylamino)-1-oxaspiro(4,5)decanes as analgesic agents
US4663343A (en) 1985-07-19 1987-05-05 Warner-Lambert Company Substituted naphthalenyloxy-1,2-diaminocyclohexyl amide compounds
GB8618188D0 (en) 1986-07-25 1986-09-03 Ici Plc Diamine compounds
EP0258095B1 (fr) * 1986-08-12 1991-06-12 Roussel-Uclaf Nouveaux dérivés de la décahydroquinoléine, leur procédé de préparation et les nouveaux intermédiaires obtenus, leur application à titre de médicaments et les compositions pharmaceutiques les renfermant
EP0258096B1 (fr) * 1986-08-21 1992-09-09 Roussel-Uclaf Dérivés de l'indane, leur procédé de préparation, leur application à titre de médicaments, les compositions pharmaceutiques les renfermant et les intermédiaires obtenus
EP0260041B1 (en) 1986-09-02 1991-01-30 Dr. Lo. Zambeletti S.p.A. 1-acyl-substituted piperidine derivatives
US4876269A (en) 1986-09-10 1989-10-24 E. I. Du Pont De Nemours And Company Benoz-fused cycloalkane trans-1,2-diamine derivatives
EP0261842B1 (en) 1986-09-17 1990-11-22 Dr. Lo. Zambeletti S.p.A. N1-acylated-(1-(phenyl or benzyl))-1,2-ethylene diamines
US4906655A (en) * 1989-01-24 1990-03-06 Warner-Lambert Company Novel 1,2-cyclohexylaminoaryl amides useful as analgesic agents

Also Published As

Publication number Publication date
PT93806B (pt) 1996-09-30
JPH02292218A (ja) 1990-12-03
JP3070930B2 (ja) 2000-07-31
US4965278A (en) 1990-10-23
CA2014957A1 (en) 1990-10-21
IE901422L (en) 1990-10-21
KR0149491B1 (ko) 1998-10-15
NZ233376A (en) 1999-08-30
ZA903016B (en) 1991-12-24
AU5368690A (en) 1990-10-25
AU622312B2 (en) 1992-04-02
EP0393696A2 (en) 1990-10-24
KR900015726A (ko) 1990-11-10
EP0393696A3 (en) 1992-09-02
IE64852B1 (en) 1995-09-06

Similar Documents

Publication Publication Date Title
PT95991A (pt) Processo para a preparacao de composicoes farmaceuticas contendo benzodiazepina
PT93079A (pt) Processo para a preparacao de composicoes farmaceuticas que contem ciclosporinas
PT87958A (pt) Processo para a preparacao de composicoes farmaceuticas, contendo antagonistas 5ht-3
FI901490A7 (fi) Aminohappojohdannaiset
FI903643A0 (fi) Menetelmä mikrohiukkasten muodossa olevan farmaseuttisen koostumuksen valmistamiseksi
DK294986D0 (da) 7-(substitueret amino)-8-((substitueret carbonyl)-methylamino)-1-oxaspiro(4.5)decaner
PT87201A (pt) Processo para a preparacao de novos derivados de cefalosporina 3,7-substituida e de composicoes farmaceuticas que os contem
ZA90336B (en) Platinum pharmaceutical agents
ATA315488A (de) Neue adenosinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate
EP0480969A4 (en) Amino acid analog cck antagonists
FI904360A7 (fi) Aminohappojohdannaiset
NZ232695A (en) Amino acid derivatives and pharmaceutical compositions thereof
GB2172263B (en) Inspection vehicle for bridges and high level roads
PT93806A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 7-(amino substituido)-8-(carbonil substituido)-metilamino-11oxa-espiro(4,5) decanos com efeito diuretico anti-inflamatorio, e cerebro-vascular
FI891145L (fi) Menetelmä antiviraalisten ja immunostimuloivien farmaseuttisten koostumusten valmistamiseksi
PT83998B (pt) Processo de preparacao de novos derivados azaciclicos e de composicoes farmaceuticas que os contem
PT81531B (pt) Processo para a preparacao de silibinina isenta de isosilibina e de composicoes farmaceuticas contendo silibinina
BR8603592A (pt) Derivados de piridazinona,processo para sua preparacao,e composicoes inseticidas
PT89036A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de ergolina
DE3767789D1 (de) Substituierte aminodihydrooxazole, -thiazole und -imidazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
IL94763A0 (en) R(-)3-quinuclidinol derivatives,their preparation and pharmaceutical compositions containing them
FI901730A7 (fi) Aminohappojohdannaisia
PT84724B (pt) Processo para a preparacao de benzimidazois e de imidazopiridinas sulfonamidas, e de composicoes farmaceuticas que os contem
DE3582466D1 (de) Aminoalkohol-derivate und verfahren zu ihrer herstellung.
PT80920B (pt) Processo para a preparacao de imidazo {1,2-a} quinolinas e de composicoes farmaceuticas que as contem

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960626

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20011231